Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Texas Biotech (TXB) -- Ignore unavailable to you. Want to Upgrade?

To: Bill Tomko who wrote (475)	12/29/1997 1:50:00 PM
From: Dauntless	Read Replies (3) \| Respond to of 834

Bill & Thread Just thought everyone might like to see the gang of thieves & villains that make up the TXB Board of Directors. John M. Pietruski Chairman of the Board, Retired Chairman and Chief Executive Officer, Sterling Drug Inc. David B. McWilliams President and Chief Executive Officer Rita R. Colwell, Ph.D. President, University of Maryland Biotechnology Institute Frank C. Carlucci Chairman,The Carlyle Group Robert J. Cruikshank Retired Senior Partner, Deloitte Touche LL James A. Thomson, Ph.D. President and Chief Executive Officer, RAND Corporation James T. Willerson, M.D. Professor and Chairman, Department of Internal Medicine The University of Texas Medical School ============================================================ Oh, and before I forget, the Advisory Director to the Company is: Denton A. Cooley, M.D. Surgeon-in-Chief, The Texas Heart Institute Dr. Cooley is well known by the investemtn community to seek out fraudulent companies as he desperately needs some extra spending cash.